VG Life Sciences Secures $2,235,000 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7a74d390-f094-47ce-b9ed-4c821b2c8da6
Date
10/4/2013
Company Name
VG Life Sciences
Mailing Address
121 Gray Ave. Santa Barbara, CA 93101
Company Description
VG Life Sciences Inc. is a drug discovery and development company researching two core technologies: Targeted Peptides and Metabolic Disruption.The Company is researching the use of these technologies in the treatment of cancer, infectious disease, and inflammation.
Website
http://www.vglifesciences.com
Transaction Type
Venture Equity
Transaction Amount
$2,235,000
Transaction Round
Undisclosed
Proceeds Purposes
This new funding will enable VG Life Sciences to begin and complete many key milestones outlined in the Company’s July Investor Letter and meet short term capital needs.
M&A Terms
Venture Investor
MedBridge Venture Fund